The first of four bellwether trials in the Xarelto® (rivaroxaban) multidistrict litigation in Louisiana Federal Court is currently underway. Plaintiff Joseph Boudreaux, 74, of Lockport, La., alleges that he developed gastrointestinal bleeding after he began taking Xarelto in 2014, requiring hospitalization, numerous blood transfusions and other serious treatments. As previously reported in this blog, this litigation...
On September 21, 2016, U.S. District Court Judge Eldon E. Fallon reset the initial bellwether trial dates in the Xarelto® (rivaroxaban) multidistrict litigation due to the NBA All-Star game and related logistical issues it would create. As previously reported in this blog, this litigation involves hundreds of lawsuits from across the country alleging that individuals...
In 2014, German drug maker Boehringer Ingelheim agreed to pay $650 million to settle approximately 4,000 Pradaxa lawsuits alleging that users suffered severe and often fatal bleeding problems after using the anticoagulant. These settled claims were part of multidistrict litigation (or MDL), that had been ongoing since April 2012 in the U.S. District Court for the...
On August 1, 2016, U.S. District Court Judge Eldon E. Fallon issued Case Management Order No. 5, which describes the bellwether cases to go to trial in the Xarelto® (rivaroxaban) multidistrict litigation. This litigation involves hundreds of lawsuits from across the country alleging that individuals taking Xarelto® suffered severe or fatal bleeding or other injuries....
The Xarelto (rivaroxaban) litigation involves numerous lawsuits from across the country alleging that individuals taking Xarelto suffered severe or fatal bleeding or other injuries. They further allege that Bayer and related companies did not adequately warn prescribing physicians or consumers of the risks associated with Xarelto, including the potential for severe or fatal bleeding and...
Copyright ©2024 Borgess Law
Law Firm Web Design by Black Fin